相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of CDK13 Was Associated with Prognosis and Expression of HIF-1α and beclin1 in Breast Cancer Patients
Xia-Liang Lu et al.
JOURNAL OF INVESTIGATIVE SURGERY (2022)
MYC as a target for cancer treatment
Michael J. Duffy et al.
CANCER TREATMENT REVIEWS (2021)
CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis
Jin-Chun Qi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1
Raphael Boehm et al.
MOLECULAR CELL (2021)
An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks
Julia Ramirez-Moya et al.
MOLECULAR CANCER (2021)
Cancer Plasticity: The Role of mRNA Translation
Laura J. Lee et al.
TRENDS IN CANCER (2021)
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou et al.
CANCER DISCOVERY (2020)
CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
Zheng Fan et al.
SCIENCE ADVANCES (2020)
Targeting Protein Synthesis in Colorectal Cancer
Stefanie Schmidt et al.
CANCERS (2020)
CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
Seung H. Choi et al.
GENES & DEVELOPMENT (2019)
Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression
Jianchu Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium
Arno L. Greenleaf
TRANSCRIPTION-AUSTIN (2019)
High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform
Sean J. Humphrey et al.
NATURE PROTOCOLS (2018)
Targeting oncogenic Myc as a strategy for cancer treatment
Hui Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
George W. Sledge et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition
Hiromi Ito et al.
BMC CANCER (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
New frontiers in translational control of the cancer genome
Morgan L. Truitt et al.
NATURE REVIEWS CANCER (2016)
eIF4F: A Retrospective
William C. Merrick
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
Kaiwei Liang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
Wenting Mi et al.
ONCOTARGET (2015)
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
Shaji K. Kumar et al.
BLOOD (2015)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors
Yanjie Zhang et al.
CELL CYCLE (2012)
Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas
Hye-Eun Kim et al.
PLOS ONE (2012)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
mRNA helicases: the tacticians of translational control
Armen Parsyan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CDC2L5, a CA-like kinase with RS domain, interacts with the ASF/SF2-associated protein p32 and affects splicing in vivo
Yasmine Even et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins
XM Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases
B Raught et al.
EMBO JOURNAL (2004)
Determinants of rapamycin sensitivity in breast cancer cells
WC Noh et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
